Increasing evidence has also suggested SPRY4‐IT1 as a prognostic factor for poor outcomes as it was associated with accelerating glioma cell proliferation, invasion, and migration via the epithelial‐mesenchymal transition.14, 15. Here, SPRY4 is linked to central nervous system cancer.